Vijaya Diagnostic Centre Limited (VIJAYA) - Total Liabilities
Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has total liabilities worth Rs5.50 Billion INR (≈ $59.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Vijaya Diagnostic Centre Limited to evaluate the company's liquid asset resilience ratio.
Vijaya Diagnostic Centre Limited - Total Liabilities Trend (2019–2026)
This chart illustrates how Vijaya Diagnostic Centre Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Vijaya Diagnostic Centre Limited total assets.
Vijaya Diagnostic Centre Limited Competitors by Total Liabilities
The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Carabao Group Public Company Limited
BK:CBG
|
Thailand | ฿5.57 Billion |
|
Guangzhou SiE Consulting Co Ltd
SHE:300687
|
China | CN¥1.38 Billion |
|
Sichuan Anning Iron and Titanium Co
SHE:002978
|
China | CN¥8.35 Billion |
|
Vivendi SA
PA:VIV
|
France | €2.51 Billion |
|
Century Plyboards (India) Limited
NSE:CENTURYPLY
|
India | Rs22.99 Billion |
|
H2O America
NASDAQ:HTO
|
USA | $2.06 Billion |
|
Tri Continental Closed Fund
NYSE:TY
|
USA | $1.92 Million |
|
Taihai Manoir Nuclear Equipment Co Ltd
SHE:002366
|
China | CN¥2.89 Billion |
Liability Composition Analysis (2019–2026)
This chart breaks down Vijaya Diagnostic Centre Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See VIJAYA equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vijaya Diagnostic Centre Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vijaya Diagnostic Centre Limited (2019–2026)
The table below shows the annual total liabilities of Vijaya Diagnostic Centre Limited from 2019 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs5.50 Billion ≈ $59.47 Million |
+15.90% |
| 2025-03-31 | Rs4.74 Billion ≈ $51.31 Million |
+46.97% |
| 2024-03-31 | Rs3.23 Billion ≈ $34.91 Million |
+5.24% |
| 2023-03-31 | Rs3.07 Billion ≈ $33.18 Million |
+25.77% |
| 2022-03-31 | Rs2.44 Billion ≈ $26.38 Million |
+34.24% |
| 2021-03-31 | Rs1.82 Billion ≈ $19.65 Million |
-12.69% |
| 2020-03-31 | Rs2.08 Billion ≈ $22.51 Million |
+4.36% |
| 2019-03-31 | Rs1.99 Billion ≈ $21.57 Million |
-- |
About Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more